Medically reviewed on December 26, 2017.
Applies to the following strengths: 15 mcg/2 mL
Usual Adult Dose for:
Additional dosage information:
Usual Adult Dose for Chronic Obstructive Pulmonary Disease - Maintenance
15 mcg inhaled by nebulization twice daily (morning and evening).
Maximum Daily Dose: 30 mcg
-Not for use to treat acute deteriorations of COPD.
Use: Long-term, twice daily (morning and evening) administration in the maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.
Renal Dose Adjustments
No adjustment recommended.
Liver Dose Adjustments
Caution is recommended when using in patients with liver dysfunction due to increased systemic exposure.
US BOXED WARNING:
-The risk of asthma-related deaths is increased in patients using long-acting beta2-adrenergic agonists (LABA). This effect was observed in a clinical trial using a different LABA and is considered to be a class effect.
-The safety and efficacy of arformoterol has not been determined in patients with asthma.
-All LABA are contraindicated in patients with asthma who are not using a long-term asthma control medication.
-Avoid use of LABA in patients not using a long-term asthma control medication.
Safety and efficacy have not been established in patients younger than 18 years.
Data not available
-Refrigerate in protective foil pouch; protect from light and excessive heat.
-After opening foil pouch, return all unopened unit-dose vials to the pouch and place in refrigerator.
-Unopened foil pouches may be stored at room temperature for up to 6 weeks.
-If stored at room temperature, discard unused portion after 6 weeks or the expiration date, whichever is sooner.
-Use opened unit-dose vials immediately
More about arformoterol
- Arformoterol Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- Support Group
- En Español
- 4 Reviews
- Drug class: adrenergic bronchodilators
Other brands: Brovana